MedTrace Logo

Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)

NCT01331200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-02-27

No results posted yet for this study

Summary

The purpose of this study is to study the safety and feasibility of mobilization of acute ischemic stroke patients treated with IV-tPA between 12-24 hours of treatment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Scott M Arnold, PT · Mayo Clinic

  • Olivia S Chavez, MS, OTR/L · Mayo Clinic

  • William D Freeman, MD · Mayo Clinic

  • James Meschia, MD · Mayo Clinic

  • Lesia Mooney, RN · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01331200 on ClinicalTrials.gov